nimbolide has been researched along with Helicobacter Infections in 1 studies
*Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blum, FC; Merrell, DS; Windham, IH; Wu, H; Wylie, MR | 1 |
1 other study(ies) available for nimbolide and Helicobacter Infections
| Article | Year |
|---|---|
In vitro antibacterial activity of nimbolide against Helicobacter pylori.
Topics: Anti-Bacterial Agents; Azadirachta; Drug Discovery; Glycerides; Helicobacter Infections; Helicobacter pylori; Humans; Limonins; Medicine, Traditional; Microbial Sensitivity Tests; Phytochemicals; Plant Extracts; Plant Leaves; Terpenes | 2022 |